semaglutide liver fat reduction CDSCO Clears Wegovy for MASH — India's First GLP-1 Approval for Disease, India's drug regulator CDSCO approved Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on Frontiers | Semaglutide ameliorates metabolism

Thus, CHAC1s upregulation enhances the survival and aggressiveness of cancer cells in the tumor microenvironment, leading to a poor prognosis (Parande et al., 2024)

Difficulty breathing If you find it hard to breathe, are short of breath, or feel like you cant catch your breath, its really important to let your healthcare provider know

This is particularly beneficial for individuals struggling to achieve weight loss through diet and exercise alone

By stimulating the body's natural fat-burning processes, both peptides can enhance the effectiveness of diet and exercise programs aimed at reducing body fat and preserving lean muscle mass